Placement Success: Amy Foreman - Wykert joins Travere Therapeutics

In rare disease, the science is only as powerful as the story told around it, to physicians, to patients, to the community that has been waiting. We're proud to announce that Amy Foreman-Wykert has joined Travere Therapeutics as Executive Director, Scientific Communications. Travere is doing meaningful work in rare kidney and liver diseases, where patients have had few options and the quality of scientific communication directly shapes clinical adoption. Amy brings the depth and credibility that work demands. Scientific communications at this level isn't just messaging. It's translating evidence into understanding for the people who need it most. #RareDisease #LifeSciences #ExecutiveSearch